Related Experiment Video
Updated: May 21, 2026
07:59
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
Diuretics and ultrafiltration in acute decompensated heart failure
G Michael Felker1, Robert J Mentz
1Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. michael.felker@duke.edu.
Journal of the American College of Cardiology
|June 9, 2012
Summary
Loop diuretics are standard for acute decompensated heart failure (ADHF), but peripheral venovenous ultrafiltration (UF) shows promise for fluid removal. Further research is needed to clarify UF
Area of Science:
- Cardiology
- Nephrology
- Critical Care Medicine
Background:
- Acute decompensated heart failure (ADHF) is characterized by congestion and volume overload.
- Loop diuretics are the primary treatment but have limitations like diuretic resistance and renal dysfunction.
- Recent trials suggest high-dose diuretics may be safer than previously thought.
Purpose of the Study:
- To review current data on diuretics and ultrafiltration (UF) for volume management in ADHF.
- To compare the efficacy and safety of diuretics versus UF.
- To identify challenges and future research directions for both treatments.
Main Methods:
- Review of existing literature on diuretic therapy in ADHF.
- Analysis of studies evaluating peripheral venovenous ultrafiltration (UF) in ADHF patients.
- Synthesis of data regarding fluid removal, quality of life, and rehospitalization rates.
Main Results:
- Loop diuretics are effective but associated with potential adverse effects.
- Preliminary studies indicate UF may offer superior fluid removal and improved patient outcomes.
- High-dose diuretic therapy might be safe, challenging prior assumptions.
Conclusions:
- Both diuretics and UF are options for managing volume overload in ADHF.
- UF presents a promising alternative with potential benefits in efficacy and patient-reported outcomes.
- Further robust clinical trials are essential to establish the definitive role of UF in ADHF management.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...